drugset / Trial / NCT00234117

Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression

NCT00234117

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if 20mg BID of Rabeprazole is effective in controlling GERD in patients with concomitant bronchial asthma and to assess improvement in asthma after reflux control.

Timeline

Start
2005-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Rabeprazole Small molecule 20 mg